Concentrations of Risk |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Risks and Uncertainties [Abstract] | |
| Concentrations of Risk |
17. Concentrations of Risk
For the nine months ended September 30, 2026, the Company had one customer that approximated 10% of total revenue, while for the nine months ended September 30, 2025, the Company had no revenue from customers that approximated 10% of total revenue.
The Company had four customers with accounts receivable balances that were 37%, 17%, 11%, and 10% of total accounts receivable as of September 30, 2026. The Company had one customer with an accounts receivable balance that was 50% of total accounts receivable as of December 31, 2025.
The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and marketable securities. Cash balances are maintained principally at major U.S. financial institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to regulatory limits. As of September 30, 2026, there is a $387 balance exceeding such limit. The Company has not experienced any credit losses associated with its cash balances in the past. The Company invests its cash equivalents in U.S. treasury bills with original maturities of six months or less.
|
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|